Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Interleukins | 1 | 2020 | 762 | 0.56 | Why? |
| Interferons | 2 | 2020 | 2885 | 0.36 | Why? |
| Disease Models, Animal | 8 | 2021 | 10998 | 0.33 | Why? |
| Mice | 16 | 2021 | 21357 | 0.28 | Why? |
| Viral Vaccines | 3 | 2020 | 7560 | 0.28 | Why? |
| Hydroxylamines | 2 | 2021 | 182 | 0.24 | Why? |
| Cytidine | 2 | 2021 | 219 | 0.23 | Why? |
| Stearic Acids | 1 | 2021 | 30 | 0.23 | Why? |
| Virus Replication | 9 | 2021 | 14331 | 0.21 | Why? |
| Newcastle disease virus | 1 | 2020 | 108 | 0.20 | Why? |
| Ribonucleosides | 1 | 2020 | 95 | 0.20 | Why? |
| Mice, Inbred BALB C | 5 | 2020 | 5814 | 0.19 | Why? |
| Forkhead Transcription Factors | 1 | 2020 | 231 | 0.19 | Why? |
| Measles virus | 1 | 2020 | 194 | 0.19 | Why? |
| Decorin | 1 | 2018 | 14 | 0.19 | Why? |
| Mice, Transgenic | 3 | 2020 | 2739 | 0.18 | Why? |
| Heterocyclic Compounds, 3-Ring | 1 | 2021 | 275 | 0.18 | Why? |
| Th1 Cells | 2 | 2020 | 1228 | 0.17 | Why? |
| Reverse Genetics | 1 | 2020 | 439 | 0.16 | Why? |
| Alphacoronavirus | 1 | 2020 | 392 | 0.15 | Why? |
| Animals | 20 | 2021 | 78931 | 0.15 | Why? |
| Prostate | 1 | 2018 | 283 | 0.15 | Why? |
| Zika Virus | 2 | 2018 | 1924 | 0.14 | Why? |
| Gene Expression Regulation, Viral | 1 | 2020 | 925 | 0.14 | Why? |
| Zika Virus Infection | 2 | 2018 | 1920 | 0.13 | Why? |
| Models, Molecular | 4 | 2021 | 7616 | 0.13 | Why? |
| Receptors, Virus | 2 | 2020 | 5659 | 0.13 | Why? |
| Methyltransferases | 1 | 2018 | 720 | 0.12 | Why? |
| Interferon-alpha | 1 | 2020 | 1442 | 0.12 | Why? |
| Acute Lung Injury | 1 | 2020 | 904 | 0.12 | Why? |
| Adjuvants, Immunologic | 1 | 2021 | 1709 | 0.11 | Why? |
| Vero Cells | 7 | 2020 | 14117 | 0.11 | Why? |
| Respiratory System | 2 | 2020 | 3213 | 0.10 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2017 | 2134 | 0.10 | Why? |
| Spike Glycoprotein, Coronavirus | 7 | 2021 | 37182 | 0.10 | Why? |
| Cell Line | 6 | 2021 | 12040 | 0.10 | Why? |
| Nanoparticles | 1 | 2020 | 2040 | 0.09 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.09 | Why? |
| Adenosine Monophosphate | 3 | 2020 | 5652 | 0.09 | Why? |
| Protein Domains | 1 | 2020 | 6563 | 0.08 | Why? |
| Disease Susceptibility | 1 | 2020 | 4002 | 0.08 | Why? |
| Betacoronavirus | 7 | 2021 | 204454 | 0.08 | Why? |
| Aging | 2 | 2020 | 3581 | 0.08 | Why? |
| Clinical Trials, Phase III as Topic | 2 | 2021 | 782 | 0.08 | Why? |
| Host Specificity | 2 | 2021 | 926 | 0.08 | Why? |
| Coronavirus Infections | 10 | 2021 | 253789 | 0.07 | Why? |
| Viral Envelope Proteins | 1 | 2017 | 3539 | 0.07 | Why? |
| Antibodies, Neutralizing | 6 | 2021 | 25288 | 0.07 | Why? |
| Mutation | 6 | 2021 | 12376 | 0.07 | Why? |
| Mice, Inbred C57BL | 3 | 2020 | 5542 | 0.07 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 3 | 2020 | 8843 | 0.07 | Why? |
| Viral Nonstructural Proteins | 2 | 2018 | 4810 | 0.06 | Why? |
| Virulence | 2 | 2020 | 2172 | 0.06 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.06 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.06 | Why? |
| Vaccines, Live, Unattenuated | 1 | 2020 | 28 | 0.06 | Why? |
| Asparagine | 1 | 2020 | 83 | 0.06 | Why? |
| Macaca nemestrina | 1 | 2020 | 71 | 0.05 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.05 | Why? |
| Heterografts | 1 | 2021 | 203 | 0.05 | Why? |
| DNA, Recombinant | 1 | 2020 | 94 | 0.05 | Why? |
| Luminescent Proteins | 1 | 2020 | 142 | 0.05 | Why? |
| Alum Compounds | 1 | 2021 | 210 | 0.05 | Why? |
| Coronavirus | 2 | 2019 | 18339 | 0.05 | Why? |
| Glycine | 1 | 2020 | 203 | 0.05 | Why? |
| Archaeal Proteins | 1 | 2018 | 45 | 0.05 | Why? |
| Protein Binding | 3 | 2021 | 11430 | 0.05 | Why? |
| Trypsin | 1 | 2020 | 209 | 0.05 | Why? |
| Cells, Cultured | 2 | 2020 | 5835 | 0.05 | Why? |
| Organogenesis | 1 | 2018 | 24 | 0.05 | Why? |
| Genetic Fitness | 1 | 2020 | 339 | 0.05 | Why? |
| Morphogenesis | 1 | 2018 | 43 | 0.05 | Why? |
| Primary Cell Culture | 1 | 2020 | 501 | 0.05 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.04 | Why? |
| Alanine | 3 | 2020 | 5687 | 0.04 | Why? |
| Organ Culture Techniques | 1 | 2018 | 119 | 0.04 | Why? |
| Homeodomain Proteins | 1 | 2018 | 93 | 0.04 | Why? |
| Amino Acid Sequence | 2 | 2021 | 6049 | 0.04 | Why? |
| Antibodies, Viral | 5 | 2021 | 51949 | 0.04 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2021 | 801 | 0.04 | Why? |
| Measles Vaccine | 1 | 2020 | 301 | 0.04 | Why? |
| Methylation | 1 | 2018 | 332 | 0.04 | Why? |
| STAT2 Transcription Factor | 1 | 2018 | 141 | 0.04 | Why? |
| Random Allocation | 1 | 2020 | 773 | 0.04 | Why? |
| Toll-Like Receptor 4 | 1 | 2020 | 390 | 0.04 | Why? |
| Antibiotic Prophylaxis | 1 | 2020 | 399 | 0.04 | Why? |
| Epitopes | 2 | 2020 | 4113 | 0.04 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.04 | Why? |
| RNA, Messenger | 2 | 2021 | 5131 | 0.04 | Why? |
| Post-Exposure Prophylaxis | 1 | 2021 | 472 | 0.04 | Why? |
| Chemoprevention | 1 | 2021 | 585 | 0.04 | Why? |
| Fetal Diseases | 1 | 2018 | 182 | 0.04 | Why? |
| Caco-2 Cells | 1 | 2020 | 1236 | 0.04 | Why? |
| Receptor, Interferon alpha-beta | 1 | 2018 | 610 | 0.04 | Why? |
| Female | 10 | 2021 | 380317 | 0.04 | Why? |
| Hydrogen Bonding | 1 | 2017 | 599 | 0.04 | Why? |
| Chiroptera | 2 | 2021 | 3530 | 0.04 | Why? |
| Mesocricetus | 1 | 2020 | 1847 | 0.04 | Why? |
| RNA Helicases | 1 | 2018 | 413 | 0.04 | Why? |
| Vaccination | 1 | 2020 | 19050 | 0.04 | Why? |
| Protein Stability | 1 | 2017 | 756 | 0.04 | Why? |
| Lung | 5 | 2021 | 31049 | 0.03 | Why? |
| Humans | 16 | 2021 | 930598 | 0.03 | Why? |
| Chemokines | 1 | 2020 | 1095 | 0.03 | Why? |
| Nose | 1 | 2020 | 1093 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2021 | 2275 | 0.03 | Why? |
| T-Lymphocyte Subsets | 1 | 2021 | 1387 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2020 | 1706 | 0.03 | Why? |
| Administration, Oral | 1 | 2021 | 2340 | 0.03 | Why? |
| Drug Resistance, Viral | 1 | 2020 | 1083 | 0.03 | Why? |
| Serine Endopeptidases | 2 | 2020 | 4606 | 0.03 | Why? |
| Vaccines, Attenuated | 1 | 2018 | 952 | 0.03 | Why? |
| Cricetinae | 1 | 2020 | 3344 | 0.03 | Why? |
| Furin | 1 | 2020 | 1054 | 0.03 | Why? |
| Alveolar Epithelial Cells | 1 | 2021 | 1445 | 0.03 | Why? |
| Nasal Mucosa | 1 | 2020 | 1218 | 0.03 | Why? |
| Cell Survival | 1 | 2018 | 1581 | 0.03 | Why? |
| Biopsy | 1 | 2021 | 2811 | 0.03 | Why? |
| Interferon-beta | 1 | 2018 | 979 | 0.03 | Why? |
| Respiratory Mucosa | 1 | 2020 | 1522 | 0.03 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2021 | 1138 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2017 | 2219 | 0.03 | Why? |
| Macaca mulatta | 1 | 2021 | 3716 | 0.03 | Why? |
| Male | 6 | 2021 | 367725 | 0.03 | Why? |
| Recombinant Proteins | 1 | 2021 | 3786 | 0.03 | Why? |
| Cystic Fibrosis | 1 | 2020 | 1104 | 0.03 | Why? |
| Swine | 1 | 2019 | 3352 | 0.03 | Why? |
| Gene Expression | 1 | 2020 | 3332 | 0.02 | Why? |
| Lung Transplantation | 1 | 2021 | 1554 | 0.02 | Why? |
| Epithelial Cells | 1 | 2021 | 3508 | 0.02 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.02 | Why? |
| Binding Sites | 1 | 2021 | 6201 | 0.02 | Why? |
| Temperature | 1 | 2017 | 2305 | 0.02 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.02 | Why? |
| Interferon Type I | 1 | 2021 | 2789 | 0.02 | Why? |
| Placenta | 1 | 2018 | 1531 | 0.02 | Why? |
| HEK293 Cells | 1 | 2020 | 8394 | 0.02 | Why? |
| Protein Conformation | 1 | 2017 | 4386 | 0.02 | Why? |
| Immunity | 1 | 2018 | 2651 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Zoonoses | 1 | 2020 | 3034 | 0.02 | Why? |
| SARS Virus | 2 | 2019 | 13021 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.02 | Why? |
| Immunity, Innate | 1 | 2021 | 6570 | 0.01 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.01 | Why? |
| Immunocompromised Host | 1 | 2018 | 5150 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2020 | 8041 | 0.01 | Why? |
| Brain | 1 | 2018 | 5133 | 0.01 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2018 | 5164 | 0.01 | Why? |
| Phylogeny | 1 | 2019 | 13341 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.01 | Why? |
| Aged | 2 | 2020 | 215776 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Pregnancy Complications, Infectious | 1 | 2018 | 11559 | 0.01 | Why? |
| Middle Aged | 2 | 2020 | 270681 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
| Adult | 1 | 2020 | 244371 | 0.00 | Why? |
Dinnon's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(163)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(259)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_